Celcuity awaits FDA review for second factory to launch cancer drugnews2026-08-17T13:19:34+00:00August 17th, 2026|Endpoints News|
GDUFA IV commitments: New onshoring incentives and meeting types for generic drugsnews2026-08-12T17:26:54+00:00August 12th, 2026|Endpoints News|
FDA rejects ITM’s radiopharma drug over manufacturing problemsnews2026-08-10T19:05:00+00:00August 10th, 2026|Endpoints News|
Bristol Myers details new $2.3B manufacturing campus in Houstonnews2026-08-10T18:20:19+00:00August 10th, 2026|Endpoints News|
Judge blocks enforcement of WuXi AppTec’s designation as Chinese military companynews2026-08-10T17:43:22+00:00August 10th, 2026|Endpoints News|
Scholar Rock drops Novo manufacturing site from SMA drug applicationnews2026-08-10T17:08:01+00:00August 10th, 2026|Endpoints News|
Merck KGaA readies tariff refunds worth €40M for life science customersnews2026-08-06T11:30:19+00:00August 6th, 2026|Endpoints News|
In a first, WuXi AppTec surpasses Lonza’s six-month revenue news2026-08-05T17:59:02+00:00August 5th, 2026|Endpoints News|
Fujifilm’s Lars Petersen exits, hands leadership baton to COO Maja Pedersennews2026-08-05T12:27:28+00:00August 5th, 2026|Endpoints News|
